Skip to content

Clinical trials

Phase 3 Bacteremia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacteremia Phase: Phase 3 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20051
20062
20071
20081
20101
20121
20132
20144
20161
20181
20191
20201
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated5
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla4
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
Pfizer2
Aarhus University Hospital1
Assistance Publique - Hôpitaux de Paris1
Basilea Pharmaceutica1
Bayer1
BioWest Therapeutics Inc1
Clinical Research Centre, Malaysia1
Cumberland Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacteremia23
Sepsis8
Gram-Positive Bacterial Infections4
Staphylococcal Infections4
Recurrence3
Bacterial Infections2
Enterobacteriaceae Infections2
Infections2
Urinary Tract Infections2
Catheter-Related Infections1

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.